Skip to main content
OpenTrials

Clinical trial condition

Splenomegaly

Explore clinical trials studying Splenomegaly. Study availability and eligibility vary by location and protocol.

27 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Splenomegaly trial results

Recruiting

Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics

NCT00001373

Conditions
ALPK1, Autoinflammation, Body Temperature Changes, +26 more
Locations
  • Childrens National Medical Center Washington D.C., District of Columbia, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Walter Reed National Medical Center Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Recruiting

GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma

NCT05992532

Conditions
Acid Sphingomyelinase Deficiency, Blood Protein Disorders, Brain Diseases, +38 more
Locations
  • Hospital Universitario de Álava Vitoria-Gasteiz, Alava, Spain
  • Hospital Universitario Torrecárdenas Almería, Spain
  • Hospital Son Espases Palma de Mallorca, Balearic Islands, Spain
  • Hospital Parc Taulí Sabadell, Barcelona, Spain
View all 23 locations
View Trial Details
Recruiting

Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

NCT03801434

Conditions
BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of Bone Marrow Nucleated Cells, +17 more
Locations
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
  • University of Utah Salt Lake City, Utah, United States
  • Fred Hutchinson cancer research center Seattle, Washington, United States
View Trial Details
Not yet recruiting

A Study of Selective Internal Radiation Therapy for the Management of Chemotherapy-induced Thrombocytopenia With Splenomegaly in Adult Subjects With Gastrointestinal Cancer

NCT07575854

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Cancer, +8 more
Locations
  • Centre Georges-François Leclerc Dijon, France
  • CHU Saint Eloi Montpellier, France
  • Centre Eugène Marquis Rennes, France
  • Institut Gustave Roussy Villejuif, France
View Trial Details
Active, not recruiting

A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

NCT03165734

Conditions
Anemia, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
Locations
  • University of Alabama at Birmingham, (UAB) Hospital, Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 207 locations
View Trial Details

Related conditions